GlassScriptPhysician profile
Daniel John Luther
NPI 1689056301
$752.91
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $25.45 · 2021: $120 · 2022: $17.43 · 2023: $158 · 2024: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $551 · Entertainment: $39.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $550.83 |
| Entertainment | $39.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $143.59 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Regeneron Healthcare Solutions, INC. | $106.39 | 2020-2024 | Eylea, Eylea Hd |
| Aerie Pharmaceuticals, INC. | $102.07 | 2021 | |
| Alcon Vision LLC | $65.72 | 2023-2024 | Hydrus Microstent, Clareon, Rocklatan |
| Tarsus Pharmaceuticals, INC. | $63.06 | 2024 | Xdemvy |
| Abbvie INC. | $53.17 | 2023-2024 | |
| Bausch & Lomb Americas INC. | $46.96 | 2023-2024 | Miebo, Xipere |
| Keystone Dental INC. | $39.38 | 2024 | |
| Mallinckrodt Hospital Products INC. | $38.41 | 2024 | Acthar |
| Glaukos Corporation | $31.97 | 2024 | Ce-Marked Kxla System |
| Harrow Eye, LLC | $23.99 | 2024 | |
| Ocular Therapeutix, INC. | $20.45 | 2023 | Dextenza |
| Allergan, INC. | $17.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Luther listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.